Syndax Pharmaceuticals
SNDX
SNDX
75 hedge funds and large institutions have $124M invested in Syndax Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 28 increasing their positions, 19 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
11% less funds holding
Funds holding: 84 → 75 (-9)
41% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 22
Holders
75
Holding in Top 10
1
Calls
$4.8M
Puts
$755K
Top Buyers
| 1 | +$3.71M | |
| 2 | +$1.92M | |
| 3 | +$1.91M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.37M |
| 5 |
6CM
683 Capital Management
New York
|
+$1.18M |
Top Sellers
| 1 | -$2.38M | |
| 2 | -$2.16M | |
| 3 | -$1.71M | |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$1.39M |
| 5 |
TAM
Tiverton Asset Management
Wilimington,
Delaware
|
-$929K |